Whitehawk Therapeutics (WHWK) Interest Coverage Ratio Growth (1y) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -14.70% |
| Jun 30, 2024 | 20.27% |
| Mar 31, 2024 | -15.97% |
| Dec 31, 2023 | -14.49% |
| Sep 30, 2023 | -18.71% |
| Jun 30, 2023 | -6.45% |
| Mar 31, 2023 | -21.80% |
| Dec 31, 2022 | 2.97% |
| Sep 30, 2022 | 53.38% |
| Jun 30, 2022 | -1,754.38% |
| Mar 31, 2022 | -1,205.37% |
| Dec 31, 2021 | -1,045.33% |
| Sep 30, 2021 | -4,682.26% |
| Dec 31, 2016 | -29,576.97% |
| Sep 30, 2016 | -98,686.10% |
| Jun 30, 2016 | -73,065.63% |
| Mar 31, 2016 | -82,057.75% |
| Dec 31, 2015 | 16.08% |
| Sep 30, 2015 | 31.12% |
| Jun 30, 2015 | 27.07% |
| Mar 31, 2015 | 15.88% |
| Dec 31, 2014 | -6.16% |
| Sep 30, 2014 | -6.54% |
| Jun 30, 2014 | 23.54% |
| Mar 31, 2014 | 33.52% |
| Dec 31, 2013 | 25.34% |
| Sep 30, 2013 | 27.29% |
| Jun 30, 2013 | -6.69% |
| Mar 31, 2013 | -2.20% |
| Dec 31, 2012 | 26.31% |
| Sep 30, 2012 | 38.22% |
| Jun 30, 2012 | 39.41% |
| Mar 31, 2012 | 22.13% |
| Dec 31, 2011 | 34.81% |
| Sep 30, 2011 | 25.27% |